The phosphoproteomic analysis uncovered significant changes of phosphorylation of nuclear proteins of CRC patients and identified DYNC1LI2 and TPR as the potential hub genes within the nucleus network. The gene discussed is DYNC1LI2; the disease is colorectal carcinoma.